Blog

Oct 31, 2024, 14:31

Development of TLS in different tumor sites from patients with high-grade serous ovarian cancer – Cancer Research Institute

Cancer Research Institute shared a post on LinkedIn:

“Aiming to improve the understanding of immune cell organization in ovarian cancer, a new study from researchers including CRI-Irvington Postdoctoral Fellow Dr. Ayana Ruffin of Emory University and former CRI-V Foundation CLIP Investigator Dr. Tullia Bruno of University of Pittsburgh sheds light on the development of tertiary lymphoid structures (TLS) in different tumor sites from patients with high-grade serous ovarian cancer.

Explore their findings, and discover how their insights could eventually lead to new treatment approaches for ovarian cancer.”

Ayana Ruffin cancer cancer awareness cancer care Cancer Research Institute CRI Emory University fight against cancer Global fight against cancer OncoDaily Oncology tertiary lymphoid structures (TLS) TLS Tullia Bruno University of Pittsburgh

King Charles III Hospitalized Following Side Effects from Cancer Treatment

Keith T. Flaherty has been elected as the AACR President-Elect for 2025-2026

MARIPOSA trial results presented at ELCC25 - BREAKING from Paris

Miranda McKeon: Battling Breast Cancer at 19, Inspiring Millions on Instagram

WHO Takes a Creative Leap in Raising Awareness for Colorectal Cancer